Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Julia F Kuder"'
Autor:
Brian A. Bergmark, Deepak L. Bhatt, P. Gabriel Steg, Andrzej Budaj, Robert F. Storey, Yared Gurmu, Julia F. Kuder, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, Christian Hamm, Jindřich Špinar, Robert G. Kiss, Frans J. Van de Werf, Gilles Montalescot, Per Johanson, Eugene Braunwald, Marc S. Sabatine, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background Coronary stent type and risk of stent thrombosis remain important factors affecting recommended duration of dual antiplatelet therapy. We investigated the efficacy and safety of long‐term ticagrelor in patients with prior coronary stenti
Externí odkaz:
https://doaj.org/article/762a1c5fb8704c70a586ea0ee8b0dab0
Autor:
Prakriti Gaba, Michelle L. O’Donoghue, Jeong-Gun Park, Stephen D. Wiviott, Dan Atar, Julia F. Kuder, KyungAh Im, Sabina A. Murphy, Gaetano M. De Ferrari, Zbigniew A. Gaciong, Kalman Toth, Ioanna Gouni-Berthold, Jose Lopez-Miranda, François Schiele, François Mach, Jose H. Flores-Arredondo, J. Antonio G. López, Mary Elliott-Davey, Bei Wang, Maria Laura Monsalvo, Siddique Abbasi, Robert P. Giugliano, Marc S. Sabatine
Publikováno v:
Circulation. 147:1192-1203
Background: Low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for atherosclerotic cardiovascular disease. However, the optimal achieved LDL-C level with regard to efficacy and safety in the long term remains unknown. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13253a16b49f4776f898e33b3823a98f
https://doi.org/10.1161/circulationaha.122.063399
https://doi.org/10.1161/circulationaha.122.063399
Autor:
Erin A. Bohula, David D. Berg, Mathew S. Lopes, Jean M. Connors, Ijlal Babar, Christopher F. Barnett, Sunit-Preet Chaudhry, Amit Chopra, Wilson Ginete, Michael H. Ieong, Jason N. Katz, Edy Y. Kim, Julia F. Kuder, Emilio Mazza, Dalton McLean, Jarrod M. Mosier, Ari Moskowitz, Sabina A. Murphy, Michelle L. O’Donoghue, Jeong-Gun Park, Rajnish Prasad, Christian T. Ruff, Mohamad N. Shahrour, Shashank S. Sinha, Stephen D. Wiviott, Sean Van Diepen, Mark Zainea, Vivian Baird-Zars, Marc S. Sabatine, David A. Morrow, Kyung Ah Im, Retu Saxena, Brandon Wiley, Carina Benson, Roman Delamed, Nedaa Skeik, Ami Chopra, Marc Judson, Scott Beegle, Boris Shkolnik, Anupama Tiwari, Gregory Wu, Abhijit Raval, Emerald Branch, Franz Rischard, Cameron Hypes, Billie Bixby, Christian Bime, Madhan Sundaram, Nancy Sweitzer, Alfredo Vazquez Sandoval, Heath White, Katherine Berg, Shahzad Shaefi, Michael Donnino, Brett Carroll, Michael Ieong, Kimberly Ackerbauer, Jaime Murphy, Ankeet Bhatt, Alexander Blood, Siddharth Patel, Victor Luu, Shraddha Narechania, Austin Lorganger, Robert Plambeck, Ali Nayfeh, Michael Sanley, Michel Del Cor, AJ Hegg, Winston Nara, Michael Snyder, Faisal Khan, Imad Shawa, Joshua Larned, Elias Collado, Mohammed Al Faiyumi, Rajeev Mehta, Sudarshan Komanapalli, Vijayadershan Muppidi, Mehul Desai, Casey Flanagan, Leonard Genovese, Tariq Haddad, Christopher King, Amber Peterson, Thane Htun, Elizabeth Pionk, Nicolas Mouawad, Chintalapudi Kumar, Kevin Nguyen, Majid Mughal, Ryan Malek, Akarsh Parekh, Christopher Provenzano, Melissa Ianitelli, Nicole Prentice-Gaytan, Adam Bykowski, Don Tait, Shelley Schendel, Varun Yalamanchili, Vasim Lala, Victor Hunyadi, Alexander Papolos, Benjamin Kenigsberg, Aarthi Shenoy, Thomas Stuckey, Douglas McQuaid, Praveen Mannam, Jeffrey McClung, Kent Nilsson, Andrew McKown, Jason Wells, David Hotchkin, Marc Jacobs, Wayne Strauss, Rick Balestra, Vikram Sahni, R. Jeffrey Snell, Hussam Suradi, Sarah Sungurlu, Jessica Kuppy, Eileen Gajo, Foster Adams, Abbas Shehadeh, Addi Suleiman, Harish Nandigam, Jihad Slim, Sardar Ijlal Babar, Dipti Baral, Talha Nawaz, Syed Abdullah Waheed, Randy Roth, Subhas Sitaula, Shahid Hayat, Jooby Babu, Jason Caberto, Victor Hsu, Robert Chang, Markian Bochan, Rafael Garcia-Cortes, Hal Skopicki, On Chen, Lauren Pilato, Paul Richman, Alexander Adler, Praveen Sudhindra, Jamie Beversdorf, Ravindra Kashyap, Parth Mehta, Borna Mehrad, Ali Ataya, Jorge Lascano, Mark Brantly, Adam Austin, Eduard Koman, Thomas Galski, Vijaya Kumar, Ayman Soubani, Nicolas Harrison, Vineet Reddy, Audrey Fonkam
Publikováno v:
Circulation. 146:1344-1356
Background: The efficacy and safety of prophylactic full-dose anticoagulation and antiplatelet therapy in critically ill COVID-19 patients remain uncertain. Methods: COVID-PACT (Prevention of Arteriovenous Thrombotic Events in Critically-ill COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f999083149829e3265fcbf720264111
https://doi.org/10.1161/circulationaha.122.061533
https://doi.org/10.1161/circulationaha.122.061533
Autor:
Michelle L. O’Donoghue, Robert P. Giugliano, Stephen D. Wiviott, Dan Atar, Anthony Keech, Julia F. Kuder, KyungAh Im, Sabina A. Murphy, Jose H. Flores-Arredondo, J. Antonio G. López, Mary Elliott-Davey, Bei Wang, Maria Laura Monsalvo, Siddique Abbasi, Marc S. Sabatine
Publikováno v:
Circulation. 146:1109-1119
Background: In FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk), the proprotein convertase subtilisin-kexin type 9 inhibitor evolocumab reduced low-density lipoprotein cholesterol (LDL-C) and ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbbf9cc5bb13ac2921d8b0595318d0e8
https://doi.org/10.1161/circulationaha.122.061620
https://doi.org/10.1161/circulationaha.122.061620
Autor:
Amy H. Auchincloss, Yvonne L. Michael, Julia F. Kuder, Jinggaofu Shi, Sumaiya Khan, Lance S. Ballester
Publikováno v:
Preventive Medicine Reports, Vol 15, Iss , Pp - (2019)
Few studies have evaluated physical activity changes in response to active transportation investments in low-income disadvantaged communities. This quasi-experimental pre-post paired location design assessed physical activity responses to a 1.5-mile
Externí odkaz:
https://doaj.org/article/d3b2528cf1c4465394c9ea3add2c3b5d
Autor:
Michelle L, O'Donoghue, Robert S, Rosenson, Baris, Gencer, J Antonio G, López, Norman E, Lepor, Seth J, Baum, Elmer, Stout, Daniel, Gaudet, Beat, Knusel, Julia F, Kuder, Xinhui, Ran, Sabina A, Murphy, Huei, Wang, You, Wu, Helina, Kassahun, Marc S, Sabatine, A, Carlisle
Publikováno v:
O'Donoghue, Michelle L; Rosenson, Robert S; Gencer, Baris; López, J Antonio G; Lepor, Norman E; Baum, Seth J; Stout, Elmer; Gaudet, Daniel; Knusel, Beat; Kuder, Julia F; Ran, Xinhui; Murphy, Sabina A; Wang, Huei; Wu, You; Kassahun, Helina; Sabatine, Marc S (2022). Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease. New England journal of medicine NEJM, 387(20), pp. 1855-1864. Massachusetts Medical Society MMS 10.1056/NEJMoa2211023
BACKGROUND Lipoprotein(a) is a presumed risk factor for atherosclerotic cardiovascular disease. Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver. METHODS We conducted a randomized, double-blind, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2288fadef6dc0ee4b5ebe62be223d5e0
https://pubmed.ncbi.nlm.nih.gov/36342163
https://pubmed.ncbi.nlm.nih.gov/36342163
Autor:
Rafael Diaz, Stephen D. Wiviott, Marc S. Sabatine, Jindřich Špinar, Itamar Raz, Assen Goudev, Ofri Mosenzon, Deepak L. Bhatt, Avivit Cahn, Ingrid Gause-Nilsson, Kyong-Soo Park, Darren K. McGuire, Kazuma Oyama, Sabina A. Murphy, Lawrence A. Leiter, John P.H. Wilding, Julia F Kuder
Publikováno v:
European Heart Journal. 43:2958-2967
Aims We investigated the associations between obesity, cardiorenal events, and benefits of dapagliflozin in patients with type 2 diabetes mellitus (T2DM). Methods and results DECLARE–TIMI 58 randomized patients with T2DM and either atherosclerotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734b4b400e1aff5ade987e11a2467a4d
https://doi.org/10.1093/eurheartj/ehab530
https://doi.org/10.1093/eurheartj/ehab530
Autor:
Benjamin M. Scirica, KyungAh Im, Sabina A. Murphy, Julia F. Kuder, Dolly A. Rodriguez, Renato D. Lopes, Jennifer B. Green, Christian T. Ruff, Marc S. Sabatine
Publikováno v:
Clinical cardiology. 45(7)
Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) assessed the cardiovascular (CV) safety of sitagliptin versus placebo on CV outcomes in patients with type 2 diabetes and CV disease and found sitagliptin noninferior to placebo. Subse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cb89e10722a1b6305ddbd8c70a1939
https://pubmed.ncbi.nlm.nih.gov/35715946
https://pubmed.ncbi.nlm.nih.gov/35715946
Autor:
Brian A. Bergmark, Nicholas A. Marston, Candace R. Bramson, Madelyn Curto, Vesper Ramos, Alexandra Jevne, Julia F. Kuder, Jeong-Gun Park, Sabina A. Murphy, Subodh Verma, Wojtek Wojakowski, Steven G. Terra, Marc S. Sabatine, Stephen D. Wiviott, Diane Carbonneau, Raphael Poulin-Robitaille, Jeffrey Wayne, Keung Lee, Samuel Mujica Trenche, Petros Dzongowski, Daniel Gaudet, Joanna Van, Dilawar Ajani, Harold Bays, John O’Mahony, Adam Janas, John Scott, Moustafa Ashraf Moustafa, Thomas Ransom, Sabrina Benjamin, Naresh Aggarwal, Pawel Bogdanski, Douglas Friars, Robert Schlosser, Boguslaw Okopien, Madhusudan Budhraja, Lawrence Feld, Leslie Klaff, Guy Tellier, Giuseppe Mazza, Iwona Wierzbicka, Ewa Jazwinska-Tarnawska, Fernando Boccalandro, Julio Rosenstock, Elizabeth Marquez, Kim Barbel-Johnson, Katarzyna Madziarska, Kenneth Heaton, Jean-Claude Tardif, John Rubino, Miguel Trevino, Katie Moriarty, Anil Gupta, Wojciech Wojakowski, James Fidelholtz, Dinesh Gupta, Hani Alasaad, Shane Christensen, Parag Shah, Stephanie Li, Mark Sherman, Andre Frechette, Cecilia Arango, Alan Egan, Sunny Srivastava, Archna Bajaj, Carlos Ince Jr, Aleksander Zurakowski
Publikováno v:
Circulation. 145(18)
Background: Genetic loss-of-function variants in ANGPTL3 are associated with lower levels of plasma lipids. Vupanorsen is a hepatically targeted antisense oligonucleotide that inhibits Angiopoietin-like 3 (ANGPTL3) protein synthesis. Methods: Adults
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a6c0c8169d6edb06e1e63884560053
https://pubmed.ncbi.nlm.nih.gov/35449408
https://pubmed.ncbi.nlm.nih.gov/35449408
Autor:
Remo H.M. Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, Thomas A. Zelniker, Minao Tang, Julia F. Kuder, Sabina A. Murphy, Andrew Hamer, Huei Wang, Anthony C. Keech, Robert P. Giugliano, Marc S. Sabatine, Brian A. Bergmark
Publikováno v:
Circulation: Cardiovascular Interventions. 15
Background: Patients with prior percutaneous coronary intervention (PCI) are at high residual risk for multiple types of coronary events within and beyond the stented lesion. This risk might be mitigated by more intensive LDL-C (low-density lipoprote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332196810d415d4229d11e5c361e4d67
https://doi.org/10.1161/circinterventions.121.011382
https://doi.org/10.1161/circinterventions.121.011382